Moneycontrol PRO
HomeNewsBusinessEconomyAs PM Modi centralizes vaccine procurement, FinMin to seek Parliamentary approval for more funds

As PM Modi centralizes vaccine procurement, FinMin to seek Parliamentary approval for more funds

The budgeted vaccination expenditure and any amount further sought through Supplementary Demand for Grants in the upcoming sessions of Parliament should be enough to fund the centre’s expanded vaccination programme, a senior government official said.

June 07, 2021 / 20:38 IST
Representational image

Central government has spent around Rs 5,000 crore of the Rs 35,000 crore vaccination budget for 2021-22 so far, and will seek Parliamentary approval for further funds only after exhausting most of that budget, Moneycontrol has learnt.

The budgeted vaccination expenditure and any amount further sought through Supplementary Demand for Grants in the upcoming sessions of Parliament should be enough to fund the Centre’s expanded vaccination programme, a senior government official said.

On June 7, Prime Minister Narendra Modi, in an address to the nation, said that the central government will make centralised vaccine procurement for 75 percent of vaccine capacities and ensure vaccine supplies to all states, thus bringing the vaccination for 18-44 age group under the centre’s ambit as well.

Private vaccination centres will be allowed to procure vaccine from the remaining 25 percent. The new vaccination policy rules come in effect from June 21. This means that from that day, the centre will distribute doses to the states for the 18-44 age group, instead of the states procuring them directly from vaccine makers.

The PM’s announcement comes in the backdrop of the criticism from many quarters on what some see as states being left on their own devices to procure vaccines, and the Supreme Court had said that the decision to allow states and union territories to procure for the 18-44 group was ‘irrational and arbitrary’.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Now that the vaccine procurement policy has again been centralized, the Rs 35,000 crore vaccination budget will be used up much earlier than was expected previously.

Chief Economic Advisor Krishnamurthy Subramanian had said last week that around 20 per cent of the 45 plus age group has been vaccinated with at least one dose.

PM’s announcement welcomed

It is understood that the centre’s earlier plan was to fully inoculate the 45 plus age group and then move to the 18-44 age group. The centre had decided to open up the latter category to states after some of them asked to do so, the person quoted above said.

“The existing budget will be used and then only Parliamentary approvals will be sought for new funds,” the official said, and added that it was difficult to predict what that additional amount will be just now.

Over the coming weeks, the Finance Ministry is expected to have a clearer picture on how much extra could be spent.

The around Rs 5,000 crore spent so far includes the Rs 4,500 crore ‘advance’ given to Bharat Biotech and Serum Institute of India for supplying vaccines to the centre till July.

Industry bodies and experts welcome the Prime Minister’s announcement on vaccines.

“The announcements today are welcome moves in the critical task of ensuring quick rollout of vaccines. Centralisation of procurement will ensure uniformity of procurement prices and create bandwidth among states to manage inoculation of their adult populations,” said TV Narendran, President of Confederation of Indian Industries.

“This would also ensure an equitable allocation of vaccines in states and was a key ask of CII too. Making the vaccines available for all the eligible population free of cost will go a long way in protecting the citizens and resuming normal economic activities at the earliest,” he said.

“Prime Minister’s address to the nation has provided a clear direction to India's vaccination programme with an avowed objective of providing free jabs to all adults, while providing a window for those willing to pay through private sector hospitals. The revised policy would remove all procedural bottlenecks for availability of vaccines to the states," ASSOCHAM Secretary General Deepak Sood said.

Arup Roychoudhury
first published: Jun 7, 2021 08:31 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai